Exhibit (e)(3)
![LOGO](https://capedge.com/proxy/SC 14D9/0001193125-18-280603/g623031g0920101134753.jpg)
August 8, 2018
PRIVATE AND CONFIDENTIAL
Invuity, Inc.
444 De Haro Street
San Francisco, CA 94107
Attention: Scott Flora, Interim President and Chief Executive Officer
Dear Scott:
This letter agreement (the “Letter Agreement”) sets forth certain understandings between Stryker Corporation (“Stryker”) and Invuity, Inc. (the “Company” and, together with Stryker, the “parties” and each a “party”) with respect to discussions between the parties relating to a possible strategic business combination (a “Transaction”).
In consideration for the time, effort and expense incurred and anticipated to be incurred by Stryker in connection with pursuing a Transaction, from the date hereof until 11:59 p.m. Eastern time on September 7, 2018 (the “Exclusivity Period”), the Company shall not nor shall it authorize or permit any of its or any its subsidiaries, affiliates, directors, officers, employees, advisors or other representatives (collectively, the “Representatives”) to, directly or indirectly, (i) initiate or solicit, or knowingly facilitate or encourage any inquiries, discussions or proposals regarding an Alternative Transaction (as defined below), (ii) continue or participate in negotiations or discussions with respect to an Alternative Transaction, or (iii) enter into any letter of intent, agreement in principle, acquisition agreement or other agreement or understanding providing for, an Alternative Transaction. Nothing contained herein shall prohibit the Company from taking and disclosing to its stockholders a position with respect to an Alternative Transaction, if required by Rule14e-2(a) and Rule14d-9 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). During the Exclusivity Period, to the extent permitted under any legal or contractual obligation or duty of confidentiality to which the Company is bound or subject, the Company shall notify Stryker of any proposal it receives regarding an Alternative Transaction within one business day of receipt of any such proposal and shall include in such notice the identity of the person or group of persons involved as well as the material terms of such proposal.
The term “Alternative Transaction” means, other than any transaction involving Stryker or any of its affiliates, any (a) direct or indirect acquisition or purchase by any person or group (as such term is used under the Exchange Act) of more than fifteen percent (15%) of the voting securities of, or equity interests in (or securities convertible into or exchangeable for voting securities of, or equity interests in) the Company or any of its subsidiaries, (b) merger, consolidation,spin-off, sale or license of all or 15% or more of the assets of the Company and its subsidiaries, taken as a whole, or a recapitalization, liquidation, dissolution or similar transaction involving the Company or any of its subsidiaries, or (c) other transaction which would reasonably be expected to impede, interfere with, prevent or materially delay a Transaction.